The vasculature of the adult spontaneously hypertensive rat (SHR) is known to express more functional L-type Ca channels than the vasculature of normotensive Wistar Kyoto (WKY) rats, but it is not known which Ca V 1.2 channel isoform is upregulated.
O
ne of the most extensively investigated animal models of hypertension is the spontaneously hypertensive rat (SHR), which progressively develops elevated blood pressure (BP) from birth and shows pronounced hypertension at adulthood. Notably, abnormalities of vascular Ca 2ϩ channels are postulated to contribute to the increased vascular tone. By 12 weeks of age, arteries of SHR exhibit greater Ca 2ϩ influx and Ca 2ϩ -dependent contractions than similar vessels from WKY rats, and this abnormality is more evident in arteries of male than female animals. 1 In addition, intracellular free [Ca 2ϩ ] is elevated in SHR rat aorta, 2 and L-type Ca 2ϩ channel current is elevated in smooth muscle cells isolated from the SHR vasculature. [3] [4] [5] [6] Finally, BP in the SHR is normalized by Ca 2ϩ channel blockers. [7] [8] [9] A similar antihypertensive effect of Ca 2ϩ channel blockers has been noted in patients with essential hypertension, leading to the suggestion that abnormalities of vascular Ca 2ϩ channels also may contribute to the human form of the disease. 10 Despite these findings, the processes that result in vascular Ca 2ϩ channel abnormalities in hypertension have not been identified. Although two earlier reports suggested unaltered or decreased dihydropyridine-binding sites in SHR vasculature, 11, 12 in pulmonary vessels Ricci et al 13 reported a higher density, implying an increased number of channel proteins. Western blots performed by Pratt et al 14 showed a greater abundance of the pore-forming ␣ 1C protein of the L-type Ca 2ϩ channel (ie, Ca V 1.2) in small mesenteric and skeletal arteries of SHR compared to WKY rats. In the same arteries, the expression of mRNA encoding the ␣ 1C subunit was increased. Although these latter findings suggest that an overabundance of Ca V 1.2 channels may represent a shared abnormality of SHR arteries, it has been difficult to define the molecular basis of this finding due to the diverse processes that regulate Ca V 1.2 expression. For example, several transcripts for the channel exist, and these may be variably expressed in different tissues. [15] [16] [17] Furthermore, in addition to transcriptional regulation, the final number of functional Ca V 1.2 channels relies on the efficiency of post-transcriptional events including translation, trafficking, membrane stability, and the effects of ␤ and ␣ 2 ␦ channel subunits on these processes.
In this regard, our laboratory and others have established that smooth muscle cells express a form of the Ca V 1.2 channel with a different amino terminus than that found in the heart. 18 -21 This finding raises the intriguing possibility that the expression level of the Ca V 1.2 channel in the vasculature may be altered in a tissue-specific manner during hypertension and other cardiovascular pathologies. Thus, the aim of the present study was: 1) to determine whether the mRNA and protein corresponding to the smooth muscle isoform of the Ca V 1.2 channel are upregulated in the vasculature of the SHR, and if confirmed, 2) to define whether this abnormality is specific for vascular smooth muscle cells or extends to other nonvascular smooth muscle expressing the same channel isoform.
Methods

Animals
Male SHR and WKY rats were obtained from Taconic Farms (Germantown, NY colony), fed standard rat chow and sacrificed at 16 to 20 weeks of age. Mean arterial BP was measured by the tail-cuff method in a subset of four SHR (183 Ϯ 6 mm Hg) and five WKY rats (109 Ϯ 8 mm Hg).
Western Blotting
Microsomal membranes were prepared from differential centrifugation (pellet from a 1-h at 100,000 g spin of the supernatant from a 5-min at 13,000 g spin) of tissue homogenized in 50 mmol/L MOPS, 250 mmol/L sucrose, 2 mmol/L EDTA, 2 mmol/L EGTA, pH 7.4 with Complete Mini protease inhibitor cocktail pellets (Roche, Indianapolis, IN). Homogenates were prepared from pulverized Ϫ80°C frozen aorta, mesenteric arteries (Dounce homogenization), left plus right ventricle, brain, and colon (Polytron homogenization) of SHR and WKY rats. In addition, samples were prepared from freshly isolated vascular smooth muscle cells from aorta dissociated in 0.1% collagenase (C-9891, Sigma, St. Louis, MO), 0.05% elastase type III (E-1027, Sigma), 2 mg/mL bovine serum albumin (BSA), 2 mmol/L CaCl 2 in Dulbecco's modified Eagle's medium (DMEM) with 1ϫ antibiotics antimycotics (GIBCO, Invitrogen, Carlsbad, CA), with cells lysed in 50 mmol/L NaCl, 25 mmol/L Tris HCl, pH 7.4, 0.5% deoxycholate, 1% octylphenyl-polyethylene glycol (Igepal CA-630, Sigma), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 2 g/mL aprotinin, and 5 g/mL leupeptin, using a modification of earlier methods (P. Boor, personal communication). The supernatant was used after a 15-min centrifugation at 10,000 g. All samples were subjected to Western blot analysis as described in detail elsewhere. 21 Two antibodies (Alomone Labs, Israel) were used for Western blotting. The first antibody (ACC-003) directed against residues 848 to 865 of the cytoplasmic II-III linker of the rat brain Ca V 1.2 channel 16 recognized all three Ca V 1.2 isoforms (including exons 1a 18 , 1b 18 , or neither) under consideration here. A second antibody (ACC-022) directed against residues 2 to 15 coded for by exon 1b of the human Ca V 1.2 channel 22 recognized only the short amino terminus encoded for by a short alternative first exon (exon 1b) expressed at very low levels in the heart. The regions of the channel representing the antibody epitopes are boxed in Fig. 1 . Also seen in Fig. 1 , the exon 1b-specific antibody recognizes channels in aorta well, but not channels in ventricle, whereas the II-III linker antibody recognizes both. Antigenic peptide in excess competes out labeling of aortic samples. In contradistinction to Saada et al, 21 we report that the lower band stained with exon 1b-specific antibody corresponds to the upper band seen with the II-III linker antibody. Thus, three size forms of the channel (see Fig. 1C ) are distinguished: full length ϳ250 kDa, amino-or carboxy-terminally truncated ϳ220 forms, and an amino-and carboxy-terminally truncated ϳ190 kDa form. Neither amino-terminally truncated form is detected by the exon 1b-specific antibody. In addition, blots were stripped and reprobed with anti-␣-actin (Sigma A-2547) or anti-␤-actin (Sigma A-5441). Films were scanned with an Alpha Innotech (San Leandro, CA) 8900 imager using AlphaEase FC software, version 3.2.3. The density values in the upper and lower bands were measured, and background was subtracted from the same size area close to the upper and lower band, respectively, avoiding trailing edge effects. The final values are the total values of the upper and lower bands of each lane.
Real-Time Reverse Transcriptase-Polymerase Chain Reaction
RNA was extracted from tissues using the RNeasy Fibrous Tissue Mini Kit (QIAGEN, Valencia, CA) following the manufacturer's instructions, and quantitated using RiboGreen RNA (Molecular Probes, Eugene, OR). In most cases, DNA standards were generated by polymerase chain reaction (PCR) amplification with the same real-time PCR primers as used for reactions. Those PCR products were quantitated, serially diluted as standard template, and cloned into TOPO cloning vectors. RNA standards were generated by in vitro transcription of linearized plasmid DNA using a MEGAscript T7 Kit (Ambion, Austin, TX). RNA standards were quantitated assuming that a 500-nucleotide standard (30 ng/L) would yield 1.1 ϫ 10 11 copies. RNA standards were used to control for tube-totube differences in reverse transcription. Reverse transcription of 50 ng of RNA samples was carried out using gene-specific primers at 50°C for 30 min, followed immediately by 40 cycles of amplification of the cDNA on a Mx3000P Real-Time QPCR System (Stratagene, La Jolla, CA). In these reactions PCR products were detected quan-titatively with the double-stranded DNA-specific dye Sybr Green (Molecular Probes). In certain other cases, RNA was reverse transcribed using random primers, and the resulting cDNA was amplified by real-time PCR. Primers for exon 1b-specific amplification (178-bp product) were forward 796: ccaccaaggttccaactatg, reverse 973: gatggtcgcattgccagcac (GenBank, M67516). The same reverse primer (497 in GenBank NM 012517) was used for exon 1a-specific amplification (147-bp product) with forward primer 351: ccagctcatgccaacatgaa (GenBank NM 012517). The Pan Ca V 1.2 primer pair used was forward 1834: ccgcagttaagtccaacgtc and reverse 2227: gagcgcagtgagttcagcaa (GenBank M59786), generating 394-bp product, amplifying message for IIS1-IIS4. All fluorescence data were analyzed with software provided by Stratagene, a melting curve performed to verify amplification of a single product, and the correct length of PCR product verified on an agarose gel.
Statistical Methods
All data are presented as mean Ϯ SD. Statistical significance was assessed using unpaired Student t test at P Ͻ .05.
Results
Expression of the ␣ 1C subunit of the channel was compared between aortas of SHR and WKY rats in Western blots, as shown in Fig. 2A . The ␣ 1C isoform emanating from exon 1b (␣ 1C/1b ) is shown above and compared to general expression of the ␣ 1C subunit using a pan-␣ 1C antibody targeting the II-III cytoplasmic linker present in all forms of the subunit ( Fig. 2A, second line) . Each lane represents an aorta from a different animal. Expression of an internal standard, smooth muscle ␣-actin ( Fig. 2A , third line), was similar between lanes. Increased expression of Ca V 1.2 channels was apparent in SHR aorta probed with either antibody. However, there was a very marked (Ͼ4ϫ) difference when the antibody recognizing the channel encoded by exon 1b was used to detect only the exon 1b-encoded isoform ( Fig. 2A,C) . To verify that increases in the ␣ 1C subunit were localized to vascular smooth muscle cells, smooth muscle cells were freshly isolated from these aorta, 93% of which stained positive for ␣-actin. Again, the SHR sample showed increased staining relative to the WKY sample using the exon 1b-specific antibody (Fig. 2B) . Cells demonstrated less post-transla- tional processing or proteolysis, as evidenced by a higher ratio of upper to lower bands on Western blots, perhaps due to a different sample preparation that avoids freezing and thawing.
Densitometric scans of the results in Fig. 2A are shown in Fig. 2C , with background near each band subtracted. The ratio of SHR/WKY expression in aorta from Fig. 2C was 4.54 with the exon 1b-specific antibody compared to 2.56 with the II-III linker antibody (P ϭ .026). We routinely observed greater actin staining in our SHR aorta blots. Although we suspect this may be due to differential retention of actin in our microsomal aorta preparations, normalization of values by actin yields an SHR/WKY ratio of 2.56 (P ϭ .0013) with the exon 1b-specific antibody, and a ratio of 1.90 (P ϭ .0056) with the II-III linker antibody (not shown). The ratio comparing the data between the two antibodies remains significant at P ϭ .015. These quantitations assumed linearity, which was explored in a separate experiment in which different amounts of one SHR aorta sample were titrated on a Western blot using the exon 1b-specific antibody against two concentrations of the same WKY sample, as seen in Fig. 2D . The densitometric results are shown in Fig. 2E . Although the SHR results are not linear, 2.5 g of SHR protein yielded a greater signal than 10 g of WKY protein. Similarly 5 g of SHR protein yielded a greater signal than 20 g of WKY protein. Therefore, a quadrupling of exon 1b-encoded ␣ 1C expression appears consistent without actin normalization.
To lend additional support to the finding that the exon 1b-encoded Ca 2ϩ channel was more abundant in SHR than in WKY vascular smooth muscle, samples were prepared from mesenteric resistance artery and shown in Fig. 3 . As with aorta, the difference in expression was clearly greater g protein samples, E) . Exon 1b-specific antibody not used for ventricle due to low expression levels of this isoform (see Figs. 1  and 2 ). The ␤-actin control for brain is not shown; it showed lesser loading only for the leftmost lane.
using the exon 1b-specific antibody than the II-III linker antibody. Densitometric scans of this and a third sample from each rat strain also support the visual impression, although in this case, the enhancement of exon 1b-encoded ␣ 1C protein appears to be threefold rather than fourfold. The ratio of SHR/WKY expression in mesenteric arteries was 3.30 with the exon 1b-specific antibody compared to 1.73 with the II-III linker antibody (P ϭ .039).
Subsequently, similar Western blots were used to determine whether the ␣ 1C subunit also was upregulated in the cardiac ventricle of SHR. Although Ca 2ϩ channels are plentiful in the heart, the ventricles only sparsely express the exon 1b-encoded ␣ 1C isoform (ie, Figs. 1 and 2A) . The WKY and SHR ventricles showed similar (P ϭ .33) expression of the Ca 2ϩ channel using the pan-␣ 1C antibody (Fig. 3C) . Thus, the ␣ 1C subunit was not upregulated in the SHR heart, which lacks the exon 1b-encoded channel isoform.
Interestingly, the upregulation of the ␣ 1C subunit also did not extend to rat brain or rat colon, tissues that express significant levels of the exon 1b-encoded Ca 2ϩ channel. The WKY and SHR brain exhibited no significant difference in ␣ 1C (P ϭ .60) or ␣ 1C/1b (P ϭ .76) expression (Fig. 3D) . Similarly, despite greater variability, no difference in the expression of ␣ 1C (P ϭ .37) and ␣ 1C/1b (P ϭ .51) was detected between WKY and SHR colon (Fig. 3E) . Thus, the Ca 2ϩ channel ␣ 1C subunit and ␣ 1C/1b isoform show a tissue-specific overexpression in SHR that may be limited to vascular smooth muscle cells. Because tissue-specific promoters have been reported for the Ca V 1.2 ␣ 1 subunit, real-time RT-PCR was used to compare mRNA encoding the ␣ 1C/1b isoform between WKY and SHR aorta. Mesenteric artery from SHR demonstrated 47% higher (using RNA standards) to 64% higher (using DNA standards) exon 1b-specific transcript levels compared to WKY rats (Fig. 4 , Table 1 ). Equivalent determinations from aorta also revealed a significant but small increase (23%) of ␣ 1C/1b transcript in SHR relative to WKY (Table 1) . However, these increases did not approach the three to fourfold increases in ␣ 1C and ␣ 1C/1b evident at the protein level (Figs. 2 and 3 ). No significant difference was noted with a Pan Ca V 1.2 primer pair or exon 1a-specific transcripts tested (Table 1) .
Discussion
These results indicate overexpression in SHR vasculature, specifically of the short amino terminus Ca V 1.2 isoform. Brain and visceral smooth muscle expressing the same isoform are not similarly affected. The modest increases in message levels could be due to increases in transcription or message stability but are insufficient to account for the differences in isoform-specific protein levels. These results are consistent with the report of a 1.53-fold increase in Ca V 1.2 message accompanied by a 3.4-fold increase in Ca V 1.2 protein in SHR mesenteric arteries.
14 Our results also suggest that the upregulation in SHR vasculature of Ca V 1.2 protein is primarily translational or post-translational, and primarily due to overexpression of the exon 1b-encoded amino-terminal isoform.
Modification of any of several post-transcriptional events could in principle explain greater Ca channel expression and increased L-type Ca current, including more efficient translation of message into protein, more efficient trafficking to the surface membrane, or a reduced rate of degradation of channel protein. Although Ca channel ␤ subunits are known to act as chaperones to direct Ca V 1.2 to the surface membrane, [23] [24] [25] the crude membrane fraction used in our study for Western blots is unlikely to be enriched in surface membranes as opposed to endoplasmic reticulum, Golgi, or endosomes, and should therefore be incapable of reflecting more efficient trafficking. Consequently, the other two explanations of our results are considered more likely.
We conclude that SHR vasculature must either translate protein from exon 1b-specific transcripts more efficiently or selectively degrade the short amino terminus form of the protein more slowly than the WKY vasculature. Either process would represent a novel form of regulation, either for the Ca V 1.2 Ca channel (␣ 1C ) or for any transport protein implicated in the pathogenesis of hypertension.
Because untranslated regions (UTRs) of mRNA can affect translation, we used RACE (rapid amplification of cDNA ends) and sequenced the 5= UTR of the exon 1b-specific form of the channel's message as before 21 and found no differences between aortas of SHR and WKY rats. Similarly, sequencing of the 3= UTR of the channel revealed no sequence differences between SHR and WKY. Thus, it is very unlikely that any genetic modification in SHR involves regulatory elements in the Ca V 1.2 gene. The relative lengths of poly(A) tails, which can affect message stability, have not been tested.
Our Western blot results do not automatically indicate increased L-type Ca current in SHR vasculature because many of the additional channels could be intracellular or exhibit low channel activity. Quantitation of Western blots indicate greater increases of exon 1b-encoded channel protein than of the reported 1.35 to 1.62 ϫ increases 5, 6 in current. Differences between results with the two antibodies suggest that some other isoform(s) of the channel must not be upregulated, although relative functional activity among such isoforms is unknown. The results reported here with Ca V 1.2 would not explain any increases in Ca current reported in cardiac myocytes in some 26 but not all studies, 27 because those cells express the exon 1a-encoded form of the channel. 18 -21 However, if ␤ 2 expression were increased in heart of SHR rats, that could result in an increase in functional Ca channels at the surface membrane, and protein kinase C (PKC) may preferentially increase activity in the cardiac form of the channel. 18 Pesic et al 28 reported that hypertension due to aortic banding causes a vascular smooth muscle cell depolarization, which in turn causes the increased Ca V 1.2 expression. Although this finding implies that hypertension causes the increase in Ca channel expression, that increased Ca channel expression most likely also contributes to the hypertension, as Ca channel blockers can normalize BP in both SHR rats 8 and hypertensive humans. 10 Differential Ca V 1.2 alternative splicing between SHR and WKY has not been assessed and could also contribute to both hypertension and its normalization by blockers. The present findings related to SHR may not apply to other animal models of hypertension or to hypertensive humans. Pesic et al 28 demonstrated that the depolarization associated with high BP in aortic-banded hypertensive rats was also associated with an increased Ca V 1.2 protein in the affected renal artery vascular smooth muscle cells. However, because channel message levels were not determined, the cause of the increased Ca channel expression could be primarily transcriptional rather than post-transcriptional. Similarly, hypertension induced by the Goldblatt model of renal artery clipping increased Ca current in the basilar artery, 29 but there have been no biochemical studies of vascular Ca channel expression using this model. Pulmonary hypertension in neonatal piglets has been associated with increases in both ␣ 1C and ␤ 2 subunits. 30 Enhanced sensitivity to Bay K 8644 has been reported for vasculature from deoxycorticosterone acetate (DOCA)-and salt-treated Sprague-Dawley rats, 31, 32 together with an indication that Ca current amplitude is also increased in the latter model. 33 However, the results reported here suggest new forms of post-transcriptional regulation of vascular Ca channels that may reveal new therapeutic targets for certain forms of hypertension.
